(CIDRAP News) – In one of the largest head-to-head studies comparing two different seasonal flu vaccines in a healthy, adult population, those who received trivalent inactivated vaccine (TIV) had fewer medical visits for respiratory illnesses compared to those who received the live attenuated influenza vaccine (LAIV).
(CIDRAP News) – Studies published today confirm that influenza A/H1N1 viruses have become widely resistant to oseltamivir (Tamiflu), the leading flu drug, without losing their ability to make people sick—thereby underlining the need for new antiviral drugs.
(CIDRAP News) – The US Food and Drug Administration (FDA) recently approved a new version of BioThrax—the nation's only licensed anthrax vaccine—that requires fewer doses and changes the injection route.
(CIDRAP News) The Rand Corp. today released its first-ever midseason survey on the uptake of the current influenza vaccine, which found that public officials still have a tall task in front of them to administer this year's record vaccine supply.
The survey indicated that about 30% of US adults had received a flu shot by mid November, but more than half of those surveyed said they didn't plan to get the immunization.
(CIDRAP News) The federal Advisory Committee on Immunization Practices (ACIP) has opened the door to voluntary anthrax vaccination for first responders, revising an 8-year-old recommendation against that step.
(CIDRAP News) An interim report from a major study of the US's only licensed anthrax vaccine suggests it may be possible to reduce local side effects without sacrificing effectiveness by changing the injection route and using fewer doses.